The Highmark Quality Management Program is designed to ensure that members receive the best quality health care, in the most appropriate setting, in the most cost-effective manner.
Quality Management follows a Continuous Quality Improvement Process model for the ongoing monitoring and analysis of relevant clinical and service quality measures. The model focuses on the early identification of problems, with the development and implementation of interventions that focus on any issues that are identified. The member is at the heart of all activities.
The purpose of the Quality Management Program is to provide the framework and the formal processes within which the organization continually assesses and improves the quality of clinical care, safety, and service to members.
Quality improvement processes are those activities that the health plan undertakes to improve the quality and safety of clinical care (including behavioral health care) and the quality of service to members.
Quality management is the integrative process that links knowledge, structure, and processes together throughout the organization to assess and improve quality.
Highmark's Health Plan Clinical Quality area, part of the Health Plan Chief Medical Officer (CMO) Organization division of Highmark, is responsible for corporation-wide coordination of clinical and service-related improvement initiatives focused on clinical care, member satisfaction, access and availability, and performance measures and outcomes for both physicians and facilities.
Quality Management is also accountable for compliance with all applicable external accrediting and regulatory entities such as the:
The organizational structure of Highmark's Health Plan Quality Management divides staff responsibilities into these distinct functional areas:
The Risk and Compliance Management area – which is part of the Enterprise Risk and Governance division – also supports the quality management program from an accreditation and regulatory compliance perspective.
These areas work together with the support of staff from other departments in Highmark, as well as external support from primary and specialty care providers to continually assess and improve the quality of clinical care, safety, and service to members.
The objectives of the Quality Program are as follows:
The Highmark Quality Program provides a framework for continuous assessment and improvement of all aspects of health care delivery and services for its membership. This involves the collection and quantitative/qualitative analyses of relevant data to identify barriers or causes for less-than-optimal performance, identification of opportunities for improvement, and implementation of interventions to improve results.
Examples of the various data sources that may be collected and analyzed include, but are not limited to, the following:
The coordination of behavioral health programs is based on an analysis of the demographic, cultural, clinical, and risk characteristics of Highmark members who utilize behavioral health services.
Highmark developed a Quality Program Description that outlines in greater detail activities to monitor and improve the quality and safety of behavioral health care and the quality of service provided to members. The document outlines the behavioral health aspects of the Quality Program and is reviewed and approved annually by the Highmark Board and appropriate Quality-related committee.
Highmark manages the inpatient utilization of behavioral health services for all members who have behavioral health care coverage through Highmark. Outpatient behavioral health services are authorized in accordance with the behavioral health benefits available for each product.
Behavioral health activities have continued to include:
As a way for Highmark to promote objective and systematic monitoring, evaluation and continuous quality improvement, various Highmark Program Committees have been established. The Program Committees are made up predominantly of health care professionals and are established by Highmark's Board of Directors.
The Enterprise Quality, Safety and Value (EQSV) Operating Committee supports the Highmark Health and Highmark Inc. EQSV Board Committee on matters impacting quality, safety, and value for the enterprise’s patients, members, and other customers. The committee’s work is to transform the enterprise’s approach to QSV from one that is focused on discrete problem solving into one that establishes and maintains a “Blended,” outcomes-driven and patient-clinician centric model across the full set of enterprise capabilities, products, and services. The Committee membership represents QSV clinical and operational expertise across all care settings, all populations, all product lines and all applicable markets. The Committee is chaired by an appointed chairperson approved by the Highmark Nominations and Governance Committee. The QSV committee provides strategic oversight to dedicated workgroups, each focused on a high-value family of measures. These specialized workgroups include Preventive Care, Pediatric Care, Cardiometabolic, Continuity and Care Coordination, among all other measures as needed, ensuring comprehensive attention to critical areas of health care quality.
The Care Management and Quality Committee is a multi-disciplinary committee representing Delaware; western and northeastern New York; western, central, and northeastern Pennsylvania; and West Virginia that is dedicated to continuous improvement of quality and care management services provided to members. The Senior Medical Director chairs the CMQC. Medical Directors and actively practicing physicians, including behavioral health and physicians in administrative positions with involvement in care management functions in hospitals, are active voting members.
The CMQC has responsibility for the review and approval of the quality, utilization management, and population health management program descriptions, evaluations, and action plans; relevant policies and procedures; utilization core performance indicators/trends; clinical criteria sets used by the plan and its delegates; review, leadership, and direction over Highmark’s care management activities and initiatives; relevant quality improvement activities; oversight/monitoring of all delegated utilization functions, credentialing policies, and desktop procedures as revised; and quality committee reports.
The CMQC is also responsible for recommending policy decisions, analyzing and evaluating the results of quality activities, ensuring provider participation in the quality program, instituting needed actions, and ensuring follow-up, as appropriate. This includes, but is not limited to, the results of quality monitoring activities completed specific to clinical outcomes, member experience, health care equity, member access to services, practitioner and provider availability, continuity and coordination of care, credentialing and recredentialing, delegation and business arrangement oversight, ongoing regulatory and accrediting body compliance, and review and input on clinical practice and preventive health guidelines.
The Clinical Policy Management Committee (CPMC) is responsible for evaluating medical and surgical procedures and techniques, developing policy guidelines for new and evolving technology and injectable drugs, determining the medical policy coverage positions, and recommending medical necessity guidelines for covered procedures.
Specialty subcommittees are utilized to review and gather recommendations regarding medical policy coverage and criteria. The specialty subcommittees are made up of external practicing physicians. The subcommittees include but may not be limited to Cardiology, Hematology/Oncology, Musculoskeletal, Neurosciences, and Pediatrics.
The focus of the Quality Improvement Program is to continuously assess and improve the care delivered by our participating practitioners/providers and the service delivered by Highmark staff to its members. The organization has the responsibility of designing, measuring, assessing, and continually improving its performance. The result is enhanced health and well-being of the populations we serve.
The scope of the Quality Improvement Program is comprehensive. It includes all Highmark members for all New York operating areas, as well as practitioners and providers who participate in the network. This includes Commercial (HMO, POS, PPO, EPO, ASO, Federal Employees Program/FEP), Medicare Advantage, and Exchange/Qualified Health Plan products and oversight of Child Health Plus, Essential Plan, and Medicaid Managed Care.
The Quality Program includes organization-wide activities, a focus on trend analysis, and development of interventions that improve the quality of care and service provided to members. The activities include clinical, service, and patient experience.
The Enterprise Risk and Governance (ERG), Quality Management (QM), Utilization Management (UM), Health Engagement Operations (HEO), and Population Health Management (PHM) teams and programs provide a framework for continuous assessment and improvement of various aspects of the health care delivery system. Cross-functional teams interface across the continuum to achieve shared goals, such as improving clinical outcomes and member experience, implementing a more robust quality strategy, supporting clinician-led care delivery and driving operational excellence.
The Health Plan Quality area's functions and responsibilities, outlined below, represent a core component of the broader Quality Management Program. This area actively integrates with other Highmark departments, expanding the program's scope throughout the organization.
The functions below are performed by various departments within the health plan/enterprise.
The scope of Enterprise Risk and Governance functions and responsibilities are described below. The functions below are maintained within the appropriate ERG teams or Highmark business areas.
The ultimate accountability for the Quality Program rests with the Board of Directors of Highmark Western and Northeastern New York, Inc.
The authority and responsibilities for administration and implementation of the Quality Program are vested in the Senior Medical Director. The Corporate Quality Management Committee regularly submits reports to the Board of Directors of Highmark in New York.
To assure that the Quality Program is implemented appropriately, key critical responsibilities related to a successful Quality Improvement Program are the shared responsibility of a variety of the committees and subcommittees across the organization.
In support of this shared responsibility, the committees, subcommittees, ad hoc committees, etc. will analyze health care-related data from monitoring activities, software program output, and formal studies as appropriate.
These committees consider a variety of actions in relation to data and a number of other activities that are defined in corporate policies. These committees include the Quality Management Committee, Network Quality and Credentials Committee, Pharmacy and Therapeutics Committee, Medical Management Clinical Committee, Vendor Process Management, Mental Health and Substance Use Disorder Parity Compliance Committee, the Behavioral Health Advisory Board Committee, Wellpoint Joint Oversight Committee, and Highmark Inc./Highmark NY Utilization Management Master Service Agreement (MSA) Joint Oversight Committee.
Results are used to compare with other local plans and regional averages, to revise goals and to target areas of improvement.
A variety of clinically based programs are in place for addressing the needs of members across the continuum of care. These include health management programs to address members with complex health care needs, those with physical or developmental disabilities, multiple chronic conditions, and severe mental illness. These programs are designed to meet the care needs of the member population through identification, participation, engagement, and targeted interventions aimed at active engagements in health care services. The goal is to maintain or improve the physical and psychosocial well-being of individuals to address health disparities through cost-effective and tailored health solutions.
Highmark adheres to the delegation requirements outlined by various regulatory bodies, including but not limited to: NCQA and the New York State Department of Health. The appropriate organization staff reviews all pre-assessments, annual assessments, medical necessity criteria and/or clinical guidelines, program documents (descriptions and evaluations) and performance reporting activities. Relevant information on delegated activities is also shared with oversight committees and the Board of Directors, as appropriate.
The effectiveness of the Quality Program is evaluated on an annual basis. The Program Evaluation addresses all aspects of the Quality Program process and activities as outlined in the Program Description/Action Plan. The Quality Program Evaluation is presented to the Quality Management Committee and the Board Directors for approval. Previously identified issues and ongoing projects are incorporated into the Action Plan for the subsequent year.
The Quality Work Plan is developed based on the outcomes and recommendations of the previous evaluation of the Quality Program. The Work Plan includes previously identified issues and Quality Program objectives for the upcoming year. Each objective is measurable and includes responsible parties and time frames for anticipated completion dates. The Work Plan will be updated on a regular basis throughout the year.
Highmark's Quality Management is responsible for evaluating member dissatisfactions, concerns, and issues related to clinical quality of care.
The Clinical Quality of Care Team of Quality Management becomes aware of potential issues/concerns and member dissatisfactions about clinical quality of care issues through information received from a variety of sources, including providers, members, and internal Highmark departments.
Members are able to make clinical quality of care complaints to the health plan.
A Clinical Quality Management Consultant (CQMC) completes the initial review of each case referred for potential quality of care issues. The CQMC, who is a registered nurse, reviews the case to determine whether there is potential for a quality issue referencing scientifically based standards of care.
A determination will be made if a clinical review is needed and applicable information is available (i.e., DOS, permission from member to use name, name and location of provider, HIPAA, if required) or if additional clarification is needed. The member concern is then forwarded to a CMQC who will request the medical record and a written response to the concerns from the provider. In New York, the medical record request will be accompanied by a request for a written response to the concerns from the provider.
Once medical records are received, the CQMC performs an assessment of the case. If the assessment dispels any concern of potential for an adverse outcome, the case is closed and filed to track the provider for any future issues.
If the potential for an adverse outcome is identified, the case is forwarded to a Medical Director for review.
When the Medical Director believes that a quality issue may be present, a written request for additional information is sent to the provider involved.
If it is determined that a quality issue is indeed present following the review of any additional information, a Level of Harm is determined by the Medical Director, and a corrective action plan is implemented if warranted.
In New York State, an acknowledgment letter of the decision regarding the clinical complaint/concern is sent to the member.
During the investigation of quality of care concerns, facility providers may be asked to supply any or all of the following:
It is the provider's responsibility to supply all requested information. Professional agreements state no fees are to be imposed for medical records needed to investigate a Clinical Quality of Care concern.
A provider or facility is placed under corrective action or sanctioning when a treatment, procedure, or service indicates a provider is not practicing in a manner that is consistent with the standards of Highmark and/or deviates from acceptable standards of care.
There are two issues when a provider can be placed under corrective action/sanctioning:
Once the Medical Director makes a determination to place the provider under corrective action, the provider will be notified in writing of:
The provider can either appeal the decision of the Medical Director, elect to abide by the corrective action plan, or make the necessary improvements (if applicable).
If an appeal is requested, a hearing with the Network Quality and Credentials Committee (NQCC) will be made available. This committee will make the decision to either uphold or overturn the original decision by the Medical Director.
After the corrective action time period has expired, the provider will be re-evaluated by the Medical Director. If the Medical Director is satisfied that all stipulations are met, the corrective action will be lifted.
If the stipulations are not met, sanctioning of the provider could occur, which may result in a provider’s inability to participate in certain programs.
Preventive Health Guidelines, which are based on scientific evidence, are available for all Highmark providers to help them in their efforts to promote healthy lifestyles and disease prevention, while reducing risk factors in the following member (patient) populations.
The Clinical Outcomes and Guidelines Quality team reviews and updates the Preventive Health Guidelines on an annual basis utilizing references such as the United States Preventive Services Task Force (USPSTF), CDC, National Institutes of Health (NIH), Centers for Medicare and Medicaid Services (CMS), etc. The Preventive Health Guidelines are placed on the applicable websites via the Provider Resource Center. A notice regarding the Preventive Schedule is made available via the member website.
The Preventive Health Guidelines, along with many other valuable clinical resources, are available on the Provider Resource Center. To access these materials, go to the Provider Resource Center and select Resources and Education from the main menu, then Clinical Quality and Education.
The Condition Management Program is designed to develop a collaborative working relationship between Highmark members, members’ providers, and Highmark clinicians to support the provider’s plan of care for members under their care. The purpose of the program is to identify members who are most at risk for significant care gaps and, therefore, a progression and/or worsening of their chronic condition. High-risk members are identified through a combination of inpatient and outpatient claims, pharmacy claims, and clinical risk scores that enable our clinicians to conduct outreach to those members by telephone.
Nurses providing condition management services by telephone are known as clinicians. Clinicians work collaboratively with the member and provider to establish realistic and attainable short and long-term goals and to encourage behavior and lifestyle changes that lead to better member self-management of their condition(s).
Members may be eligible to receive health coaching for these chronic conditions, such as, but not limited to, the following:
For Federal Employee Program (FEP) members, one of the following rare disease cohorts may also apply:
Providers, members, and family members can learn about the program and refer to the program by calling the 24/7 health information line using the phone number on the back of their insurance card.
Highmark recognizes the importance of coordination of care as part of the quality continuum. There are programs and policies in place to ensure coordination of medical, behavioral health, or other community support for members. This process enables Highmark to inform the membership of health care needs that require follow-up, training in self-care, and other measures to promote their health.
Highmark facilitates the continuity and coordination of medical care across the delivery system and collaborates with behavioral health practitioners to monitor and improve coordination between medical and behavioral health care. The communication between PCPs and behavioral health specialists is assessed as part of the Highmark Quality Program.
Network organizational providers such as hospitals, emergency facilities, ambulatory surgery centers, home health agencies, and skilled nursing facilities must promote continuity and coordination of care for network members by communicating with PCPs when care is delivered to their patients. PCPs should expect a written description of the care given to their patients any time services have been rendered by these providers.
Medical record documentation can be assessed at any time using medical record documentation standards that are based on the most recent regulatory guidelines (CMS, NYSDOH, NCQA).
Medical record documentation will be assessed using the most recent NYSDOH prenatal guidelines. These standards will be used to evaluate compliance in appropriate prenatal medical care for pregnant women.
Review of these medical records will improve continuity and quality of patient care by assuring timely, legible, accurate, and comprehensive documentation of patient-provider interaction. It will allow Highmark of Western and Northeastern New York to target areas of opportunity to provide education to practitioners on their documentation and areas where medical care can be improved.
Medical record documentation standards are based on regulatory guidelines. The standards are reviewed for updates annually.
The medical records for review can be derived from any of the following sources:
Highmark recognizes the importance of patient safety programs; therefore, the Highmark Patient Safety Program focuses on the development of activities which assess and improve the plan’s patient safety efforts.
Many activities have been developed to enhance patient safety, including development of patient-safety-focused, written educational offerings for member and provider communications.
Clinical Quality – Quality of Care is responsible for evaluating member dissatisfactions, concerns, and issues related to clinical quality of care and for initiating appropriate action in response to them.
Clinical Quality – Quality of Care becomes aware of clinical quality of care dissatisfactions through information received from a number of sources, including providers and members as well as internal Highmark departments. Tracking mechanisms enable Clinical Quality – Quality of Care to monitor the information received over time and identify improvement opportunities.
|
Who Does It? |
What Is Done?
|
|
|---|---|---|
|
Step 1 |
Registered Nurse from Clinical Quality – Quality of Care |
Performs a preliminary review to determine whether there is potential for a quality issue. Decision made to either track the accepted case in a database of similar issues involving the provider; or requests and reviews medical records according to Clinical Quality – Quality of Care policy.
|
|
Step 2 |
A Highmark Medical Director |
Performs a case review.
|
|
Step 3 |
A Highmark Medical Director |
Reviews the case with any additional information provided by the involved provider.
|
|
Step 4 |
Provider/Practitioner |
May choose to appeal (within 30 days) these actions before a subcommittee of the Highmark Network Quality and Credentials Committee. |
|
Step 5 |
Clinical Quality – Quality of Care staff |
|
The Healthcare Effectiveness Data and Information Set (HEDIS®) is a set of standardized performance measures designed to ensure purchasers and consumers have the information they need to reliably compare the performance of all managed health care plans. Each participating plan reports data for the same measures, so you know you are making comparisons based on similar information.
To ensure these measures encompass data from the entire calendar year, health plans are asked to evaluate and report their results from the prior year. The Plan may be required to report on members from distinct product lines as required to meet and/or maintain National Committee for Quality Assurance (NCQA) accreditation, Centers for Medicare and Medicaid Services (CMS), and/or Office of Personnel Management (OPM) requirements, and/or the Pennsylvania and/or Delaware Department of Health and/or New York Department of Health (PA DOH, DE DOH, NYS DOH) requirements.
Understanding the categories in which plans are rated can help members make a choice based on what is important to them. HEDIS® determines quality and value by measuring success in the following areas:
This reporting occurs annually and requires the use of administrative claims data, as well as supplemental data feeds through the use of electronic clinical data systems and medical record abstracted data.
HEDIS® is a registered trademark of the National Committee for Quality Assurance (NCQA).
Annual member satisfaction surveys are conducted, using a statistically valid sample of the membership, to ensure that the plan identifies potential areas for service quality improvements.
Results of the survey are reviewed by Clinical Services - Quality and internal ad-hoc workgroups. The findings are then reported to the Care Management and Quality Committee. Member satisfaction is also monitored through review of member dissatisfactions, complaints, and appeals.
Highmark contracts with SPH Analytics, an independent research firm certified by the National Committee for Quality Assurance (NCQA) and the Centers for Medicare and Medicaid Services (CMS), to conduct the annual Commercial and Medicare Advantage Consumer Assessment of Healthcare Providers and Systems (CAHPS) survey and the Qualified Health Plan Enrollee Experience Survey (EES).
The surveys are used to gather information about the overall experiences of our members and to identify areas for improvement.
The CAHPS and QHP EES survey results are updated annually and are available on the Provider Resource Center's CAHPS/QHP EES Results page.
CAHPS® is a registered trademark of the Agency for Healthcare Research and Quality (AHRQ).
Highmark considers the pursuit of quality improvement in health care to be a shared effort. While each facility must assess its own needs, establish meaningful goals, and monitor its own progress, Highmark can assist by providing data and opportunities for analysis. Highmark appreciates the cooperation of facilities in collecting data and making good use of it toward improvement of quality in health care services.
Highmark maintains a comprehensive Medicare Advantage Quality Improvement Program (QIP), which includes the mandatory Chronic Care Improvement Program (CCIP) as required by the Centers for Medicare and Medicaid Services (CMS). This program is designed to promote the effective management of chronic diseases across the Medicare Advantage plans. Annually, Highmark completes and attests to the effectiveness of its CCIP within the CMS Health Plan Management System (HPMS), demonstrating adherence to regulatory standards by submitting both a detailed Plan Section and an Annual Update on its progress.
Through its Quality Management teams, Highmark conducts systematic and ongoing follow-up on identified chronic conditions. For instance, a recent project focused on improving the percentage of diabetic members receiving annual diabetic retinal eye exams. This involved cross-functional teams performing quantitative and qualitative analyses, leading to targeted interventions aimed at enhancing health outcomes and participant engagement. This approach ensures continuous improvement in care delivery, aligning with CMS's objective of better health for our members.
The Clinical Outcomes and Guidelines team coordinates the development and implementation of member outreach and communication initiatives designed to promote evidence‑based preventive care, chronic disease management, and overall health improvement. Outreach activities include targeted mailings, educational materials, digital communications, and other engagement strategies that provide health information, reminders, and encouragement for recommended clinical services.
Member outreach initiatives are data-driven and prioritize populations with identified gaps in care, focusing on preventive health screenings such as breast, cervical, and colorectal cancer screenings, as well as other quality measures. Outreach strategies are tailored, when appropriate, to support accessibility, health literacy, language needs, and member preferences.
In support of reducing healthcare disparities, Highmark team collaborates with internal and external partners to identify and address inequities in access, utilization, and health outcomes across diverse member populations. Healthcare disparities activities utilize the Highmark Community Support tool to help identify members with social and community-based needs and connect them with available community resources and support services.
Highmark identified a need for Spanish-speaking members to have access to educational materials translated into their native language. Several of Highmark’s educational materials have been translated into Spanish and are available on the Provider Resource Center's Educational Resources – Member and Provider page.
Highmark is continuing to evaluate the need for other educational materials to be translated and will implement new translated materials as necessary.
Highmark has both prospective and retrospective coding programs in place to support correct risk scoring of its members. These programs are essential for ensuring the accuracy and completeness of each member's health record, allowing for appropriate risk adjustment. Highmark also provides resources and education to providers to facilitate accurate capture of ongoing conditions on an annual basis.
Goals of Risk Adjustment Programs:
Provider documentation and coding information is available in the Clinical Quality and Education section of the Provider Resource Center.
Highmark can accept up to 36 diagnoses for a date of service. If you have more diagnosis codes than the system allows, Highmark has developed the following process to submit additional diagnosis codes:
Example: Billing system with a maximum amount of 12 diagnoses per claim:
If you wish to submit additional diagnosis codes beyond the count of 24 by utilizing 99499 on another separate claim, a modifier 25 must be affixed to the procedure code along with a claim charge of $0.00 to avoid a duplicate claim.
Note: A denial message will show on the EOB stating that this line item could not be processed because a charge amount was not attached. Even though this line item is denied, Highmark will still capture the diagnosis codes affiliated with this procedure code. If a diagnosis code of value was omitted from the original billing, Availity® will allow you to submit the additional codes using 99499 on eligible 1500 claims.
Activities of the Highmark Quality Program, including activities of the staff, medical directors, and the Network Quality and Credentials Committee, may be afforded protections as peer review activities under state and federal law. Such protected activities include:
Accordingly, network providers and other peer review bodies (such as hospital quality review committees) may furnish information requested by the Highmark Quality Program and the confidentiality of such information will be maintained and protected pursuant to applicable state and federal laws.
The following entities, which serve the noted regions, are independent licensees of the Blue Cross Blue Shield Association: Western and Northeastern PA: Highmark Inc. d/b/a Highmark Blue Cross Blue Shield, Highmark Choice Company, Highmark Health Insurance Company, Highmark Coverage Advantage Inc., Highmark Benefits Group Inc., First Priority Health, First Priority Life, Highmark Care Benefits Inc., or Highmark Senior Health Company. Central and Southeastern PA: Highmark Inc. d/b/a Highmark Blue Shield, Highmark Benefits Group Inc., Highmark Health Insurance Company, Highmark Choice Company or Highmark Senior Health Company. Delaware: Highmark BCBSD Inc. d/b/a Highmark Blue Cross Blue Shield. West Virginia: Highmark West Virginia Inc. d/b/a Highmark Blue Cross Blue Shield, Highmark Health Insurance Company or Highmark Senior Solutions Company. Western NY: Highmark Western and Northeastern New York Inc. d/b/a Highmark Blue Cross Blue Shield. Northeastern NY: Highmark Western and Northeastern New York Inc. d/b/a Highmark Blue Shield.
All references to “Highmark” in this document are references to the Highmark company that is providing the member’s health benefits or health benefit administration and/or to one or more of its affiliated Blue companies.
All revisions to this Highmark Provider Manual (the “manual” or “Highmark Provider Manual”) are controlled electronically. All paper copies and screen prints are considered uncontrolled and should not be relied upon for any purpose.